在瘤学中个性化传统中医:将宏观状态与微观目标相结合
Jingmin Ji1,2, Qing Wen1,2, Yuerufei Yu1,2
1The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310053, China.
The American journal of Chinese medicine
|November 18, 2025
概括
传统中医 (TCM) 通过考虑个体患者的个人资料和整体健康,提供个性化癌症治疗. 这种方法旨在改善癌症患者的治疗结果和生活质量.
科学领域:
- 在瘤学瘤学.
- 综合医学是一个整体的医学.
- 传统中国医药 传统中国医药
背景情况:
- 由于复杂的病原和瘤异质性,癌症给全球健康带来了重大挑战.
- 目前的癌症疗法由于个体的变化和治疗反应的多样性,往往产生不满意的结果.
- 多维患者因素,包括压力,心理健康和饮食,影响癌症的进展和治疗的有效性.
研究的目的:
- 审查传统中医 (TCM) 在个性化癌症治疗中的临床应用.
- 根据TCM原则,划出瘤管理的战略框架.
- 推进基于证据的TCM治疗恶性瘤的方法,整合"国家目标差异化和治疗" (Bianzheng Lunzhi) 的概念.
主要方法:
- 对TCM在个性化癌症治疗中的临床应用和战略框架的审查.
- 整合了"国家目标差异化和治疗" (白春季) 概念.
- 专注于瘤管理的整体和个性化方法.
主要成果:
- 作为一种补充疗法,TCM在缓解症状和改善生活质量方面表现出有效性.
- 根据特定的临床表现量身定制的个性化TCM干预措施,增强了治疗个性化.
- "国家目标差异化和治疗"框架为基于TCM的癌症护理提供了一个系统的方法.
结论:
- 综合评估和个性化治疗对于改善癌症预后结果和生活质量至关重要.
- 传统医疗为癌症管理提供了一个整体的,个性化的治疗选择.
- 基于证据的TCM,利用系统的框架,如"国家目标差异化和治疗",提供了个性化癌症治疗的科学方法.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:18Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K